February 4, 2025 - 11:54

On January 29, 2025, the leveraged finance and private equity sectors united in London for the inaugural Leveraged Finance Fights Melanoma event, raising an impressive £1.4 million. This significant sum will directly benefit the Melanoma Research Alliance, an organization dedicated to advancing research and treatment options for melanoma, a serious form of skin cancer.
The event attracted numerous professionals from the finance industry, who participated in various activities aimed at increasing awareness and funding for melanoma research. Attendees included leading figures in leveraged finance, private equity, and related fields, all rallying behind the cause. The evening featured inspiring speeches from melanoma survivors and experts in the field, highlighting the urgent need for continued research and innovative treatments.
The success of this inaugural event not only demonstrates the commitment of the finance community to social responsibility but also sets the stage for future fundraising initiatives aimed at combating melanoma and supporting those affected by this disease.